Cluster Headache Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Cluster Headache Epidemiology Forecast Report Coverage

Expert Market Research's “Cluster Headache Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of cluster headache. It projects the future incidence and prevalence rates of cluster headache cases across various populations.  The study covers age, gender, and type as major determinants of the cluster headache population. The report highlights patterns in the prevalence of cluster headache over time and projects future trends based on multiple variables.

Cluster Headache Understanding: Disease Overview

Cluster headache is a primary neurological disorder characterized by severe, unilateral head pain, typically centered around the eye or temporal region, aligning with trigeminal autonomic cephalalgia epidemiology patterns. It occurs due to hypothalamic dysregulation and activation of the trigeminal-autonomic reflex, leading to symptoms such as lacrimation, nasal congestion, and ptosis. Attacks are short but extremely intense, often occurring in cyclical “cluster” patterns. The condition is classified into episodic and chronic forms based on remission duration and attack persistence.

Cluster Headache Epidemiology Perspective

The cluster headache epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the cluster headache epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for cluster headache and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Daniel San-Juan et al. (2024), cluster headache affects approximately 0.1% of the population globally, a mean prevalence of 53 per 100,000 (range 3–150 per 100,000), while Arne May et al., 2023 estimates prevalence to be between 0.1% and 0.2%. 
• As per Daniel San-Juan et al. (2024), incidence ranges from 2.07 to 9.8 per 100,000 person-years, with nearly 80% of patients experiencing episodic forms, indicating characteristic episodic cluster headache distribution patterns. 
• According to Leon S. Moskatel et al. (2025), onset typically occurs between 20 and 40 years of age, with peak prevalence between 20 and 50 years, highlighting cluster headache age distribution trends. 
• As per Arne May et al. (2023) and Daniel San-Juan et al. (2024), cluster headache shows a male predominance of 3–4:1, now revised to 1.3–2.6:1, reflecting evolving gender disparity in cluster headache recognition. 
• According to Arne May et al. (2023) and Merck & Co., Inc., cluster headache is not associated with significant mortality but contributes to substantial morbidity, indicating persistent cluster headache morbidity patterns globally.

Read more about this report - Request a Free Sample

Country-wise Cluster Headache Epidemiology

The cluster headache epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of cluster headache across the covered regions reflects low prevalence with variability in diagnosis and reporting, indicating neurological disorder prevalence variability. According to Merck & Co., Inc., prevalence in the United States is approximately 0.1%, with higher incidence in men and typical onset between 20 and 40 years of age. In France, prevalence is estimated at 0.146%, while in Japan and India, underdiagnosis highlights gaps in recognition and epidemiological reporting.

Cluster Headache: Treatment Overview

Cluster headache management focuses on rapid relief of acute attacks and prevention of recurrence, reflecting evolving cluster headache treatment response patterns. Acute treatments include high-flow oxygen therapy and fast-acting medications such as subcutaneous triptans. Preventive therapy commonly involves calcium channel blockers such as verapamil, along with corticosteroids and lithium in select cases. Newer CGRP inhibitors and neuromodulation techniques may be considered in refractory cases to reduce attack frequency and severity.

Key Questions Answered

• What are the key findings of cluster headache epidemiology in the 8 major markets?
• What will be the total number of patients with cluster headache across the 8 major markets during the forecast period?
• What was the country-wise cluster headache epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of cluster headache patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of cluster headache during the forecast period of 2026-2035?
• What are the currently available treatments for cluster headache?
• What are the disease risks, signs, symptoms, and unmet needs of cluster headache?

Scope of the Cluster Headache Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of cluster headache based on several factors.
• Cluster Headache Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The cluster headache report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Chronic Daily Headache Epidemiology Forecast

Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market